致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human PLAU/uPA (active form), Avi-His-tag
目录号 NBL-242190
别名 PLAU/uPA; PLAU; Urokinase; ATF; UPA; URK; u-PA; BDPLT5; QPD
外观 see COA
分子量 Ser21-Leu431
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 P00749-1
备注2
目录号 规格 价格 库存状态  
NBL-242190-100ug 100ug Inquire Inquire
NBL-242190-1mg 1mg Inquire Inquire
NBL-242190-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human PLAU/uPA (active form), Avi-His-tag


Catalog#:

NBL-242190


Description:

NebuSelect™ Recombinant Biotinylated Human PLAU/uPA (active form), Avi-His-tag(Cat#NBL-242190) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Ser21-Leu431, which consists of two chains: Long chain A (Ser21-Phe177) and chain B (Ile179-Leu 431). The long chain A is further cleaved to yield a short chain A (Lys156-Phe 177) and N-Terminus fragment (Ser21-Lys155).


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 49.3 kDa. Due to protein lysis and glycosylation, the protein migrates to 24-26 kDa(long chain A), 35-38 kDa(chain B) and 52-60 kDa(long chain A&chain B) based on Bis-Tris PAGE result.


Target Name:

PLAU/uPA; PLAU; Urokinase; ATF; UPA; URK; u-PA; BDPLT5; QPD


Target Information:

Plasminogen activator, urokinase (uPA) is a secreted serine protease whose Dysregulation is often accompanied by various cancers. PLAU inhibition could suppress tumor growth. Collectively, PLAU is necessary for tumor progression and can be a diagnostic and prognostic biomarker in HNSCC.


Amino Acid Sequence: 

Ser21-Leu431


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品